← Evidence map

ArticleAnnals of medicine and surgery (2012)2026

FDA approval of SetPoint System: the first neuroimmune modulation therapy for rheumatoid arthritis.

Abdullah Imtiaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41675797